Background. A pacemaker system consists of one or two leads connected to a device that is implanted into a pocket formed just below the collarbone. This pocket is typically subcutaneous, that is, located just above the pectoral fascia. Even though the size of pacemakers has decreased markedly, complications due to superficial implants do occur. An alternative technique would be intramuscular placement of the pacemaker device, but there are no randomized controlled trials (RCTs) to support this approach, which is the rationale for the Placement Of Cardiac PacemaKEr Trial (POCKET). The aim is to study if intramuscular is superior to subcutaneous placement of a pacemaker pocket. Methods. In October 2016, we started to enroll 200 consecutive patients with an indication for bradycardia pacemaker implantation. Patients are randomized to random block sizes, stratified by age group (cut-off: 65 years) and sex, and then randomized to either subcutaneous or intramuscular implant. A concealed allocation procedure is employed, using sequentially numbered, sealed envelopes. Pocket site is blinded to the patient and in all subsequent care. The primary endpoint is patient overall satisfaction with the pocket location at 24 months as measured using a visual analog scale (VAS) 0-10. Secondary endpoints are: complications, patient-reported satisfaction at 1, 12, and 24 months (overall satisfaction, pain, discomfort, degree of unsightly appearance, movement problems, and sleep problems due to device). Conclusions. POCKET is a prospective interventional RCT designed to evaluate if intramuscular is superior to subcutaneous placement of a bradycardia pacemaker during a two-year follow-up.
Arrhythmia, Complication, Pacemaker, Pocket, Randomized controlled trial
Financial support: Region Gävleborg funded this research project.
Peter Magnusson Cardiology Research Unit Department of Medicine Karolinska Institutet Karolinska University Hospital/Solna SE-171 76 Stockholm, Sweden email@example.com
Share this Article
Related Content In Interventional Cardiology
FOREWORD – HEART INTERNATIONAL – VOLUME 17 ISSUE 2 – 2023
Heart International. 2023;17(2):1
In this issue of Heart International, we are delighted to present a collection of insightful articles that encompass a wide spectrum of topics within the field of cardiovascular medicine. As we navigate the landscape of cardiovascular disease, heart failure, preventative cardiology, interventional procedures and the latest advancements in research, we find ourselves on the cutting […]
Conduction System Pacing: Have We Finally Found the Holy Grail of Physiological Pacing?
Heart International. 2023;17(2):2-5
For decades, right ventricular pacing (RVP) has been the leading pacing technique and has been proven to be effective in treating patients with symptomatic bradycardia. However, dyssynchrony caused by non-physiological ventricular activation results in pacing-induced cardiomyopathy occurs in approximately 15% of patients with >20% ventricular pacing after 5 years.1 Pacing of the right ventricular septum has […]
FOREWORD – HEART INTERNATIONAL – VOLUME 17 ISSUE 1 – 2023
Heart International. 2023;17(1):1
Welcome to the latest issue of Heart International. This edition includes a range of articles on topics showcasing the latest advances in our understanding and treatment of cardiovascular disease. We begin with focus on the hereditary cardiac disorder, hypertrophic cardiomyopathy, which previously had a limited treatment options. However, with the approval of the myosin inhibitor, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!